- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Endoparasiticide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Endoparasiticide market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Veterinary Hospitals or Clinics accounting for % of the Endoparasiticide global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Ear Tags segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Endoparasiticide include Boehringer Ingelheim, Elanco, Zoetis, Merck, and Virbac, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Endoparasiticide market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Ear Tags
Tablets
Injectables
Feed Additives
Market segment by Application can be divided into
Veterinary Hospitals or Clinics
Animal Farms
Home Care Settings
The key market players for global Endoparasiticide market are listed below:
Boehringer Ingelheim
Elanco
Zoetis
Merck
Virbac
Novartis AG
Ceva Sante Animlae
Bayer AG
Eli Lilly
Vetoquinol
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Endoparasiticide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Endoparasiticide, with price, sales, revenue and global market share of Endoparasiticide from 2019 to 2022.
Chapter 3, the Endoparasiticide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Endoparasiticide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Endoparasiticide market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Endoparasiticide.
Chapter 13, 14, and 15, to describe Endoparasiticide sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Endoparasiticide Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Endoparasiticide Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Ear Tags
1.2.3 Tablets
1.2.4 Injectables
1.2.5 Feed Additives
1.3 Market Analysis by Application
1.3.1 Overview: Global Endoparasiticide Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Veterinary Hospitals or Clinics
1.3.3 Animal Farms
1.3.4 Home Care Settings
1.4 Global Endoparasiticide Market Size & Forecast
1.4.1 Global Endoparasiticide Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Endoparasiticide Sales in Volume (2017-2028)
1.4.3 Global Endoparasiticide Price (2017-2028)
1.5 Global Endoparasiticide Production Capacity Analysis
1.5.1 Global Endoparasiticide Total Production Capacity (2017-2028)
1.5.2 Global Endoparasiticide Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Endoparasiticide Market Drivers
1.6.2 Endoparasiticide Market Restraints
1.6.3 Endoparasiticide Trends Analysis
2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Endoparasiticide Product and Services
2.1.4 Boehringer Ingelheim Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Elanco
2.2.1 Elanco Details
2.2.2 Elanco Major Business
2.2.3 Elanco Endoparasiticide Product and Services
2.2.4 Elanco Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Zoetis
2.3.1 Zoetis Details
2.3.2 Zoetis Major Business
2.3.3 Zoetis Endoparasiticide Product and Services
2.3.4 Zoetis Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Endoparasiticide Product and Services
2.4.4 Merck Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Virbac
2.5.1 Virbac Details
2.5.2 Virbac Major Business
2.5.3 Virbac Endoparasiticide Product and Services
2.5.4 Virbac Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Novartis AG
2.6.1 Novartis AG Details
2.6.2 Novartis AG Major Business
2.6.3 Novartis AG Endoparasiticide Product and Services
2.6.4 Novartis AG Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Ceva Sante Animlae
2.7.1 Ceva Sante Animlae Details
2.7.2 Ceva Sante Animlae Major Business
2.7.3 Ceva Sante Animlae Endoparasiticide Product and Services
2.7.4 Ceva Sante Animlae Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bayer AG
2.8.1 Bayer AG Details
2.8.2 Bayer AG Major Business
2.8.3 Bayer AG Endoparasiticide Product and Services
2.8.4 Bayer AG Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Endoparasiticide Product and Services
2.9.4 Eli Lilly Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Vetoquinol
2.10.1 Vetoquinol Details
2.10.2 Vetoquinol Major Business
2.10.3 Vetoquinol Endoparasiticide Product and Services
2.10.4 Vetoquinol Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Endoparasiticide Breakdown Data by Manufacturer
3.1 Global Endoparasiticide Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Endoparasiticide Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Endoparasiticide
3.4 Market Concentration Rate
3.4.1 Top 3 Endoparasiticide Manufacturer Market Share in 2021
3.4.2 Top 6 Endoparasiticide Manufacturer Market Share in 2021
3.5 Global Endoparasiticide Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Endoparasiticide Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Endoparasiticide Market Size by Region
4.1.1 Global Endoparasiticide Sales in Volume by Region (2017-2028)
4.1.2 Global Endoparasiticide Revenue by Region (2017-2028)
4.2 North America Endoparasiticide Revenue (2017-2028)
4.3 Europe Endoparasiticide Revenue (2017-2028)
4.4 Asia-Pacific Endoparasiticide Revenue (2017-2028)
4.5 South America Endoparasiticide Revenue (2017-2028)
4.6 Middle East and Africa Endoparasiticide Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Endoparasiticide Sales in Volume by Type (2017-2028)
5.2 Global Endoparasiticide Revenue by Type (2017-2028)
5.3 Global Endoparasiticide Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Endoparasiticide Sales in Volume by Application (2017-2028)
6.2 Global Endoparasiticide Revenue by Application (2017-2028)
6.3 Global Endoparasiticide Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Endoparasiticide Sales by Type (2017-2028)
7.2 North America Endoparasiticide Sales by Application (2017-2028)
7.3 North America Endoparasiticide Market Size by Country
7.3.1 North America Endoparasiticide Sales in Volume by Country (2017-2028)
7.3.2 North America Endoparasiticide Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Endoparasiticide Sales by Type (2017-2028)
8.2 Europe Endoparasiticide Sales by Application (2017-2028)
8.3 Europe Endoparasiticide Market Size by Country
8.3.1 Europe Endoparasiticide Sales in Volume by Country (2017-2028)
8.3.2 Europe Endoparasiticide Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Endoparasiticide Sales by Type (2017-2028)
9.2 Asia-Pacific Endoparasiticide Sales by Application (2017-2028)
9.3 Asia-Pacific Endoparasiticide Market Size by Region
9.3.1 Asia-Pacific Endoparasiticide Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Endoparasiticide Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Endoparasiticide Sales by Type (2017-2028)
10.2 South America Endoparasiticide Sales by Application (2017-2028)
10.3 South America Endoparasiticide Market Size by Country
10.3.1 South America Endoparasiticide Sales in Volume by Country (2017-2028)
10.3.2 South America Endoparasiticide Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Endoparasiticide Sales by Type (2017-2028)
11.2 Middle East & Africa Endoparasiticide Sales by Application (2017-2028)
11.3 Middle East & Africa Endoparasiticide Market Size by Country
11.3.1 Middle East & Africa Endoparasiticide Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Endoparasiticide Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Endoparasiticide and Key Manufacturers
12.2 Manufacturing Costs Percentage of Endoparasiticide
12.3 Endoparasiticide Production Process
12.4 Endoparasiticide Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Endoparasiticide Typical Distributors
13.3 Endoparasiticide Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Endoparasiticide Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Endoparasiticide Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer Ingelheim Major Business
Table 5. Boehringer Ingelheim Endoparasiticide Product and Services
Table 6. Boehringer Ingelheim Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Elanco Basic Information, Manufacturing Base and Competitors
Table 8. Elanco Major Business
Table 9. Elanco Endoparasiticide Product and Services
Table 10. Elanco Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Zoetis Basic Information, Manufacturing Base and Competitors
Table 12. Zoetis Major Business
Table 13. Zoetis Endoparasiticide Product and Services
Table 14. Zoetis Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Endoparasiticide Product and Services
Table 18. Merck Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Virbac Basic Information, Manufacturing Base and Competitors
Table 20. Virbac Major Business
Table 21. Virbac Endoparasiticide Product and Services
Table 22. Virbac Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 24. Novartis AG Major Business
Table 25. Novartis AG Endoparasiticide Product and Services
Table 26. Novartis AG Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Ceva Sante Animlae Basic Information, Manufacturing Base and Competitors
Table 28. Ceva Sante Animlae Major Business
Table 29. Ceva Sante Animlae Endoparasiticide Product and Services
Table 30. Ceva Sante Animlae Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 32. Bayer AG Major Business
Table 33. Bayer AG Endoparasiticide Product and Services
Table 34. Bayer AG Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 36. Eli Lilly Major Business
Table 37. Eli Lilly Endoparasiticide Product and Services
Table 38. Eli Lilly Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Vetoquinol Basic Information, Manufacturing Base and Competitors
Table 40. Vetoquinol Major Business
Table 41. Vetoquinol Endoparasiticide Product and Services
Table 42. Vetoquinol Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Endoparasiticide Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Endoparasiticide Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Endoparasiticide, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Endoparasiticide Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Endoparasiticide Production Site of Key Manufacturer
Table 48. Endoparasiticide New Entrant and Capacity Expansion Plans
Table 49. Endoparasiticide Mergers & Acquisitions in the Past Five Years
Table 50. Global Endoparasiticide Sales by Region (2017-2022) & (K Units)
Table 51. Global Endoparasiticide Sales by Region (2023-2028) & (K Units)
Table 52. Global Endoparasiticide Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Endoparasiticide Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Endoparasiticide Sales by Type (2017-2022) & (K Units)
Table 55. Global Endoparasiticide Sales by Type (2023-2028) & (K Units)
Table 56. Global Endoparasiticide Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Endoparasiticide Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Endoparasiticide Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Endoparasiticide Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Endoparasiticide Sales by Application (2017-2022) & (K Units)
Table 61. Global Endoparasiticide Sales by Application (2023-2028) & (K Units)
Table 62. Global Endoparasiticide Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Endoparasiticide Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Endoparasiticide Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Endoparasiticide Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Endoparasiticide Sales by Country (2017-2022) & (K Units)
Table 67. North America Endoparasiticide Sales by Country (2023-2028) & (K Units)
Table 68. North America Endoparasiticide Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Endoparasiticide Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Endoparasiticide Sales by Type (2017-2022) & (K Units)
Table 71. North America Endoparasiticide Sales by Type (2023-2028) & (K Units)
Table 72. North America Endoparasiticide Sales by Application (2017-2022) & (K Units)
Table 73. North America Endoparasiticide Sales by Application (2023-2028) & (K Units)
Table 74. Europe Endoparasiticide Sales by Country (2017-2022) & (K Units)
Table 75. Europe Endoparasiticide Sales by Country (2023-2028) & (K Units)
Table 76. Europe Endoparasiticide Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Endoparasiticide Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Endoparasiticide Sales by Type (2017-2022) & (K Units)
Table 79. Europe Endoparasiticide Sales by Type (2023-2028) & (K Units)
Table 80. Europe Endoparasiticide Sales by Application (2017-2022) & (K Units)
Table 81. Europe Endoparasiticide Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Endoparasiticide Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Endoparasiticide Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Endoparasiticide Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Endoparasiticide Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Endoparasiticide Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Endoparasiticide Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Endoparasiticide Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Endoparasiticide Sales by Application (2023-2028) & (K Units)
Table 90. South America Endoparasiticide Sales by Country (2017-2022) & (K Units)
Table 91. South America Endoparasiticide Sales by Country (2023-2028) & (K Units)
Table 92. South America Endoparasiticide Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Endoparasiticide Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Endoparasiticide Sales by Type (2017-2022) & (K Units)
Table 95. South America Endoparasiticide Sales by Type (2023-2028) & (K Units)
Table 96. South America Endoparasiticide Sales by Application (2017-2022) & (K Units)
Table 97. South America Endoparasiticide Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Endoparasiticide Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Endoparasiticide Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Endoparasiticide Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Endoparasiticide Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Endoparasiticide Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Endoparasiticide Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Endoparasiticide Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Endoparasiticide Sales by Application (2023-2028) & (K Units)
Table 106. Endoparasiticide Raw Material
Table 107. Key Manufacturers of Endoparasiticide Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Endoparasiticide Typical Distributors
Table 111. Endoparasiticide Typical Customers
List of Figures
Figure 1. Endoparasiticide Picture
Figure 2. Global Endoparasiticide Revenue Market Share by Type in 2021
Figure 3. Ear Tags
Figure 4. Tablets
Figure 5. Injectables
Figure 6. Feed Additives
Figure 7. Global Endoparasiticide Revenue Market Share by Application in 2021
Figure 8. Veterinary Hospitals or Clinics
Figure 9. Animal Farms
Figure 10. Home Care Settings
Figure 11. Global Endoparasiticide Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Endoparasiticide Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Endoparasiticide Sales (2017-2028) & (K Units)
Figure 14. Global Endoparasiticide Price (2017-2028) & (US$/Unit)
Figure 15. Global Endoparasiticide Production Capacity (2017-2028) & (K Units)
Figure 16. Global Endoparasiticide Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Endoparasiticide Market Drivers
Figure 18. Endoparasiticide Market Restraints
Figure 19. Endoparasiticide Market Trends
Figure 20. Global Endoparasiticide Sales Market Share by Manufacturer in 2021
Figure 21. Global Endoparasiticide Revenue Market Share by Manufacturer in 2021
Figure 22. Endoparasiticide Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Endoparasiticide Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Endoparasiticide Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Endoparasiticide Sales Market Share by Region (2017-2028)
Figure 26. Global Endoparasiticide Revenue Market Share by Region (2017-2028)
Figure 27. North America Endoparasiticide Revenue (2017-2028) & (USD Million)
Figure 28. Europe Endoparasiticide Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Endoparasiticide Revenue (2017-2028) & (USD Million)
Figure 30. South America Endoparasiticide Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Endoparasiticide Revenue (2017-2028) & (USD Million)
Figure 32. Global Endoparasiticide Sales Market Share by Type (2017-2028)
Figure 33. Global Endoparasiticide Revenue Market Share by Type (2017-2028)
Figure 34. Global Endoparasiticide Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Endoparasiticide Sales Market Share by Application (2017-2028)
Figure 36. Global Endoparasiticide Revenue Market Share by Application (2017-2028)
Figure 37. Global Endoparasiticide Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Endoparasiticide Sales Market Share by Type (2017-2028)
Figure 39. North America Endoparasiticide Sales Market Share by Application (2017-2028)
Figure 40. North America Endoparasiticide Sales Market Share by Country (2017-2028)
Figure 41. North America Endoparasiticide Revenue Market Share by Country (2017-2028)
Figure 42. United States Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Endoparasiticide Sales Market Share by Type (2017-2028)
Figure 46. Europe Endoparasiticide Sales Market Share by Application (2017-2028)
Figure 47. Europe Endoparasiticide Sales Market Share by Country (2017-2028)
Figure 48. Europe Endoparasiticide Revenue Market Share by Country (2017-2028)
Figure 49. Germany Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Endoparasiticide Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Endoparasiticide Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Endoparasiticide Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Endoparasiticide Revenue Market Share by Region (2017-2028)
Figure 58. China Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Endoparasiticide Sales Market Share by Type (2017-2028)
Figure 65. South America Endoparasiticide Sales Market Share by Application (2017-2028)
Figure 66. South America Endoparasiticide Sales Market Share by Country (2017-2028)
Figure 67. South America Endoparasiticide Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Endoparasiticide Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Endoparasiticide Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Endoparasiticide Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Endoparasiticide Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Endoparasiticide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Endoparasiticide in 2021
Figure 79. Manufacturing Process Analysis of Endoparasiticide
Figure 80. Endoparasiticide Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
